Literature DB >> 17264098

Effect of fenofibrate on oxidative DNA damage and on gene expression related to cell proliferation and apoptosis in rats.

Jihei Nishimura1, Yasuaki Dewa, Masako Muguruma, Yuichi Kuroiwa, Hiroaki Yasuno, Tomomi Shima, Mailan Jin, Miwa Takahashi, Takashi Umemura, Kunitoshi Mitsumori.   

Abstract

To investigate the relationship between fenofibrate (FF) and oxidative stress, enzymatic, histopathological, and molecular biological analyses were performed in the liver of male F344 rats fed 2 doses of FF (Experiment 1; 0 and 6000 ppm) for 3 weeks and 3 doses (Experiment 2; 0, 3000, and 6000 ppm) for 9 weeks. FF treatment increased the activity of enzymes such as carnitine acetyltransferase, carnitine palmitoyltransferase, fatty acyl-CoA oxidizing system, and catalase in the liver. However, it decreased those of superoxide dismutase in the liver in both experiments. Increased 8-hydroxy-2'-deoxyguanosine levels in liver DNA and lipofuscin accumulation were observed in the treated rats of Experiment 2. In vitro measurement of reactive oxygen species (ROS) in rat liver microsomes revealed a dose-dependent increase due to FF treatment. Microarray (only Experiment 1) or real-time reverse transcription-polymerase chain reaction analyses revealed that the expression levels of metabolism and DNA repair-related genes such as Aco, Cyp4a1, Cat, Yc2, Gpx2, Apex1, Xrcc5, Mgmt, Mlh1, Gadd45a, and Nbn were increased in FF-treated rats. These results provide evidence of a direct or indirect relationship between oxidative stress and FF treatment. In addition, increases in the expression levels of cell cycle-related genes such as Chek1, Cdc25a, and Ccdn1; increases in the expression levels of cell proliferation-related genes such as Hdgfrp3 and Vegfb; and fluctuations in the expression levels of apoptosis-related genes such as Casp11 and Trp53inp1 were observed in these rats. This suggests that cell proliferation induction, apoptosis suppression, and DNA damage due to oxidative stresses are probably involved in the mechanism of hepatocarcinogenesis due to FF in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264098     DOI: 10.1093/toxsci/kfm011

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  18 in total

1.  AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats.

Authors:  Hans Ludwig Schäfer; Wolfgang Linz; Eugen Falk; Maike Glien; Heiner Glombik; Marcus Korn; Wolfgang Wendler; Andreas W Herling; Hartmut Rütten
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

2.  In vitro cytogenetic toxicity of bezafibrate in human peripheral blood lymphocytes.

Authors:  M Topaktas; N E Kafkas; S Sadighazadi; E S Istifli
Journal:  Cytotechnology       Date:  2017-01-17       Impact factor: 2.058

3.  PPARalpha-dependent activation of cell cycle control and DNA repair genes in hepatic nonparenchymal cells.

Authors:  Aijuan Qu; Yatrik M Shah; Tsutomu Matsubara; Qian Yang; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2010-09-02       Impact factor: 4.849

4.  ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.

Authors:  Justyna Drukala; Katarzyna Urbanska; Anna Wilk; Maja Grabacka; Ewa Wybieralska; Luis Del Valle; Zbigniew Madeja; Krzysztof Reiss
Journal:  Mol Cancer       Date:  2010-06-22       Impact factor: 27.401

5.  E2/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma.

Authors:  Shu Nu Chang-Lee; Hsi-Hsien Hsu; Marthandam Asokan Shibu; Tsung-Jung Ho; Chih-Hao Tsai; Ming-Cheng Chen; Chuan-Chou Tu; Vijaya Padma Viswanadha; Wei- Wen Kuo; Chih-Yang Huang
Journal:  Pathol Oncol Res       Date:  2016-10-18       Impact factor: 3.201

6.  Fenofibrate, a PPARα agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB.

Authors:  Nan Zuo; Xiaoyu Zheng; Hanzhe Liu; Xiaoli Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes.

Authors:  Linda R Peterson; Xuntian Jiang; Ling Chen; Anne C Goldberg; Marsha S Farmer; Daniel S Ory; Jean E Schaffer
Journal:  J Lipid Res       Date:  2020-05-11       Impact factor: 5.922

8.  Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics.

Authors:  Aiming Liu; Andrew D Patterson; Zongtao Yang; Xinying Zhang; Wei Liu; Fayang Qiu; He Sun; Kristopher W Krausz; Jeffrey R Idle; Frank J Gonzalez; Renke Dai
Journal:  Drug Metab Dispos       Date:  2009-02-27       Impact factor: 3.922

9.  Caspase 2 activation and ER stress drive rapid Jurkat cell apoptosis by clofibrate.

Authors:  Fabio Penna; Fabrizio Pin; Domiziana Costamagna; Patrizia Reffo; Francesco Maria Baccino; Gabriella Bonelli; Paola Costelli
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Toxicogenomic biomarkers for liver toxicity.

Authors:  Naoki Kiyosawa; Yosuke Ando; Sunao Manabe; Takashi Yamoto
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.